Cell Line Development For Biopharmaceutical Production

Dr. Lina Chakrabarti from AstraZeneca leads a team focused on cell line development, crucial for biotherapeutics manufacturing. She improves the efficiency, predictability and robustness of this process and has developed innovative methodologies and technologies. A key aspect is ensuring a production cell line originates from a single cell progenitor for consistent product quality. Chakrabarti uses the Namocell Single Cell Dispenser for sorting single cells for clonal growth, significantly reducing time and costs, while maintaining quality and sterility. The device is compact, quick to set up, user-friendly, and cost-effective.